CTX-1211 is a selective and orally active melanocortin 4 receptor (MC4R) agonist with an EC50 of 0.38 nM. It enhances the effects of liraglutide in suppressing food intake and promoting weight loss, supporting anorectic and weight-reducing activities. CTX-1211 is primarily employed in research related to obesity and other metabolic disorders.
Target:
Melanocortin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
